📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity. (2017)

First Author: Nawaf MG

Attributed to: Understanding basic mechanisms of CD4 immunity and its regulation in relation to autoimmunity and cancer pathogenesis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.1700088

PubMed Identifier: 28646041

Publication URI: http://europepmc.org/abstract/MED/28646041

Type: Journal Article/Review

Volume: 199

Parent Publication: Journal of immunology (Baltimore, Md. : 1950)

Issue: 3

ISSN: 0022-1767